Inflammatory gene expression associates with hepatitis B virus cccDNA- but not integrant-derived transcripts in HBeAg negative disease

Inflammatory gene expression associates with hepatitis B virus cccDNA- but not integrant-derived transcripts in HBeAg negative disease

Chronic hepatitis B virus (HBV) infection is a global health problem that presents as a spectrum of liver disease, reflecting an interplay between the virus and the host immune system. HBV genomes exist as episomal covalently closed circular DNA (cccDNA) or chromosomal integrants. The relative contr...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Magri, A, Harris, JM, D'Arienzo, V, Minisini, R, Jühling, F, Wing, PAC, Rapetti, R, Leutner, M, Testoni, B, Baumert, TF, Zoulim, F, Balfe, P, Pirisi, M, McKeating, JA
Format:	Journal article
Sprache:	English
Veröffentlicht:	MDPI 2022

Ähnliche Einträge

Inflammatory Gene Expression Associates with Hepatitis B Virus cccDNA- but Not Integrant-Derived Transcripts in HBeAg Negative Disease
von: Andrea Magri, et al.
Veröffentlicht: (2022-05-01)

Gene Editing Technologies to Target HBV cccDNA
von: Maria Guadalupe Martinez, et al.
Veröffentlicht: (2022-11-01)

CTCF regulates hepatitis B virus cccDNA chromatin topology
von: Dobrica, MO, et al.
Veröffentlicht: (2023)

CTCF regulates hepatitis B virus cccDNA chromatin topology
von: Dobrica, MO, et al.
Veröffentlicht: (2024)

A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesis
von: Wing, P, et al.
Veröffentlicht: (2019)

Estimation of hepatitis B virus cccDNA persistence in chronic infection using within-host evolutionary rates
von: Lythgoe, KA, et al.
Veröffentlicht: (2020)

Mechanism of Hepatitis B Virus cccDNA Formation
von: Lei Wei, et al.
Veröffentlicht: (2021-07-01)

Effect of HBeAg/anti-HBe coexistence on HBeAg seroconversion in treatment-naïve chronic hepatitis B patients with peginterferon-α
von: Kaimin Song, et al.
Veröffentlicht: (2025-02-01)

Is the function of the HBeAg really unknown?
von: David R. Milich
Veröffentlicht: (2019-09-01)

Mathematical investigation of HBeAg seroclearance
von: Sarah Kadelka, et al.
Veröffentlicht: (2019-08-01)

Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels
von: Ko, C, et al.
Veröffentlicht: (2018)

Differential plasma microRNA profiles in HBeAg positive and HBeAg negative children with chronic hepatitis B.
von: Thilde Nordmann Winther, et al.
Veröffentlicht: (2013-01-01)

HBV pregenome RNA as a predictor of spontanous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients
von: Guangjun Song, et al.
Veröffentlicht: (2023-11-01)

Manifestations of perihepatic lymph nodes in acute flare of chronic hepatitis B: association with HBeAg status and with HBeAg seroconversion.
von: Yen-Ling Ko, et al.
Veröffentlicht: (2015-01-01)

Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks
von: Xiaomei Wang, et al.
Veröffentlicht: (2020-10-01)

Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus.
von: Kouichi Kitamura, et al.
Veröffentlicht: (2018-06-01)

Asiatic acid inhibits HBV cccDNA transcription by promoting HBx degradation
von: Ranran Li, et al.
Veröffentlicht: (2024-10-01)

Overexpression of DNA-methyltransferases in persistency of cccDNA pool in chronic hepatitis B
von: D S Kostyushev, et al.
Veröffentlicht: (2017-11-01)

A novel nomogram for predicting HBeAg seroclearance in HBeAg-positive chronic hepatitis B patients treated with nucleos(t)ide analogues
von: Yan Gu, et al.
Veröffentlicht: (2024-01-01)

HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
von: Cheng-Yuan Peng, et al.
Veröffentlicht: (2015-04-01)

cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B
von: Patricia Gita Naully, et al.
Veröffentlicht: (2025-01-01)

Mechanisms of Hepatitis B Virus cccDNA and Minichromosome Formation and HBV Gene Transcription
von: Andoni Gómez-Moreno, et al.
Veröffentlicht: (2024-04-01)

Super-Resolution Microscopy Analysis of Hepatitis B Viral cccDNA and Host Factors
von: Phuong Thi Bich Doan, et al.
Veröffentlicht: (2023-05-01)

Lamivudine therapy in HBeAg negative chronic hepatitis B patients
von: E. Guclu, et al.
Veröffentlicht: (2014-04-01)

HBeAg negative chronic hepatitis B in South Asia
von: Ananta Shrestha, et al.
Veröffentlicht: (2016-11-01)

Prediction of cccDNA dynamics in hepatitis B patients by a combination of serum surrogate markers
von: Kim, KS, et al.
Veröffentlicht: (2025)

HBV cccDNA: The Molecular Reservoir of Hepatitis B Persistence and Challenges to Achieve Viral Eradication
von: André Boonstra, et al.
Veröffentlicht: (2025-01-01)

Targeting HBV cccDNA Levels: Key to Achieving Complete Cure of Chronic Hepatitis B
von: Wei He, et al.
Veröffentlicht: (2024-12-01)

IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome.
von: Gianna Aurora Palumbo, et al.
Veröffentlicht: (2015-01-01)

Hepatitis B virus cccDNA is formed through distinct repair processes of each strand
von: Lei Wei, et al.
Veröffentlicht: (2021-03-01)

Envelope antibody HBeIgG and HBV DNA in HBeAg-seronegative young adults in Nigeria
von: Mathew Folaranmi Olaniyan, et al.
Veröffentlicht: (2023-09-01)

Circadian control of hepatitis B virus replication
von: Zhuang, X, et al.
Veröffentlicht: (2021)

A PCR assay to quantify patterns of HBV transcription
von: D'Arienzo, V, et al.
Veröffentlicht: (2019)

DNA Sensor ABCF1 Phase Separates With cccDNA to Inhibit Hepatitis B Virus Replication
von: Caiyue Ren, et al.
Veröffentlicht: (2024-12-01)

Early Steps of Hepatitis B Life Cycle: From Capsid Nuclear Import to cccDNA Formation
von: João Diogo Dias, et al.
Veröffentlicht: (2021-04-01)

cccDNA-Targeted Drug Screen Reveals a Class of Antihistamines as Suppressors of HBV Genome Levels
von: Ee Chee Ren, et al.
Veröffentlicht: (2023-09-01)

Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP‐Based Therapy
von: Michel Bazinet, et al.
Veröffentlicht: (2021-11-01)

Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx–DDB1 InteractionSummary
von: Kazuma Sekiba, et al.
Veröffentlicht: (2019-01-01)

Correction: IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome.
von: Gianna Aurora Palumbo, et al.
Veröffentlicht: (2015-01-01)

Baseline value of intrahepatic HBV DNA over cccDNA predicts patient’s response to interferon therapy
von: Di Mu, et al.
Veröffentlicht: (2017-07-01)